Rani Therapeutics (RANI) IPO Opens Modestly Higher After Weak Pricing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. SPY
2. NVDA
3. CRWV
4. IRON
5. EYPT
6. SLGN
7. STLD
8. CHRD
9. AMZN
10. CLF

Go back to Rani Therapeutics (RANI) IPO Opens Modestly Higher After Weak Pricing

Rani Therapeutics Holdings, Inc (RANI) Prices 6.7M Share IPO at $11/sh

July 30, 2021 8:57 AM EDT

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics, today announced the pricing of its initial public offering of 6,666,667 shares of Class A common stock at a price to the public of $11.00 per share. The gross proceeds to Rani from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $73.3 million. In addition, Rani has granted the underwriters a 30-day option to purchase up... More